Biyolojik Afetler ve COVID-19

Yıl 2020, Cilt: 1 Sayı: 1, 41 - 50, 15.06.2020

Bahadır Tercan

Öz

Biyolojik afetler; doğal olarak oluşan salgınlarla, öldürücü bir mikroorganizmanın kazara salınması ya da kasıtlı olarak kullanılmasıyla ve böcek istilasıyla oluşmaktadır. Tarihsel süreçte birçok biyolojik hastalık etkeni salgın oluşturarak ya da biyolojik silah ajanı olarak kullanılıp milyonlarca insanın ölmesine neden olmuştur. Günümüzde ise küresel boyutta bir salgın oluşturarak biyolojik afete neden olan biyolojik hastalık etkini yeni tip koronavirüs-19’dur. 2019 yılının son günlerinde Çin’in Wuhan kentinde ortaya çıkmıştır. 2020 yılı içerisinde tüm dünyayı etkisi altına alarak milyonlarca insanı etkilenmesine, yüz binlerce kişinin hayatını kaybetmesine ve küresel anlamda ekonomik ve psiko-sosyal sorunlara neden olmuştur.

Anahtar Kelimeler

Afet, Biyolojik Afetler, COVID-19, COVID-19’un Afet Boyutu

Destekleyen Kurum

-

Proje Numarası

-

Kaynakça

• Anderson, P. D. (2012). Bioterrorism: toxins as weapons. Journal of pharmacy practice, 25(2), 121-129.
• Anderson, P. D., & Bokor, G. (2012). Bioterrorism: pathogens as weapons. Journal of pharmacy practice, 25(5), 521-529.
• Artenstein, A. W. (2016). Biological Attack. In G. R. Ciottone (Ed.), Ciottone’s Disaster Medicine (pp. 480-488): Elsevier.
• Balali-Mood, M., Moshiri, M., & Etemad, L. (2013). Medical aspects of bio-terrorism. Toxicon, 69, 131-142.
• Barras, V., & Greub, G. (2014). History of biological warfare and bioterrorism. Clinical microbiology and infection, 20(6), 497-502.
• Centers for Disease Control and Prevention (CDC) (2012). Emergency preparedness and response, bioterrorism agents/diseases. URL: https://emergency.cdc.gov/agent/agentlist-category.asp#catdef (Erişim Tarihi: 20.04.2020)
• Chan, J. F., Lau, S. K., To, K. K., Cheng, V. C., Woo, P. C., & Yuen, K. Y. (2015). Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clinical microbiology reviews, 28(2), 465-522.
• Cho, S. Y., Kang, J. M., Ha, Y. E., Park, G. E., Lee, J. Y., Ko, J. H., & Ryu, J. G. (2016). MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. The lancet, 388(10048), 994-1001.
• Constantin, C. M., Martinelli, A. M., Bonney, E. A., & Strickland, O. L. (2003). Smallpox: an update for nurses. Biological research for nursing, 4(4), 282-294.
• Darling, R. G., & Noste, E. E. (2016). Future biological and chemical weapons. In G. R. Ciottone (Ed.), Ciottone's Disaster Medicine (pp. 489–498): Elsiver.
• Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P. Y., & Feikin, D. R. (2012). Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. The Lancet infectious diseases, 12(9), 687-695.
• Dökmeci, H. (2018). Toksikolojik çevresel ve endüstriyel afetler. İstanbul: Nobel Tıp Kitabevleri.
• Erköseoğlu, İ. (2018). Biyolojik afetler. In M. Yılmaz & R. K. Akbulut (Eds.), Doğal afetler ve afet yönetimi (pp. 1-23). Erzurum: Atatürk Üniversitesi Açıköğretim Fakültesi Yayını.
• Feikin, D. R., Alraddadi, B., Qutub, M., Shabouni, O., Curns, A., Oboho, I. K., & Madani, T. A. (2015). Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014. Emerging infectious diseases, 21(11), 2029.
• Flora, S. J. S. (2019). Biological warfare agents: History and modern-day relevance. In S. J. S. Flora & V. Pachauri (Eds.), Handbook on Biological Warfare Preparedness (pp. 1-11): Elsevier.
• Frischknecht, F. (2003). The history of biological warfare. EMBO reports, 4(S1), S47-S52.
• Gursky, E., Inglesby, T. V., & O'Toole, T. (2003). Anthrax 2001: observations on the medical and public health response. Biosecurity and Bioterrorism: Biodefense strategy, practice, and science, 1(2), 97-110.
• He, F., Deng, Y., & Li, W. (2020). Coronavirus Disease 2019 (COVID‐19): What we know? Journal of medical virology.
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
• Hui, D. S., Memish, Z. A., & Zumla, A. (2014). Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Current opinion in pulmonary medicine, 20(3), 233-241.
• Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., de La Vega, M. A., & Kuhn, J. H. (2020). Ebola virus disease. Nature reviews disease primers, 6(1), 1-31.
• Kearney, A., & Pettit, C. (2016). Introduction to Biological Agents and Pandemics. In G. R. Ciottone (Ed.), Ciottone’s Disaster Medicine (Vol. 2nd Edition, pp. 696-698): Elsevier.
• Kılıç, D. (2020). Afetlerde halk sağlığına giriş. In C. Çapık & D. Kılıç (Eds.), Afetlerde halk sağlığı hizmetleri (pp. 4-26). Erzurum: Atatürk Üniversitesi Açıköğretim Fakültesi Yayını.
• Kılıç, S. (2006). Biyolojik silahlar ve biyoterörizm. Türk hijyen ve deneysel biyoloji dergisi, 63(1), 1-20.
• Leung, G. M., Hedley, A. J., Ho, L. M., Chau, P., Wong, I. O., Thach, T. Q., & Ferguson, N. M. (2004). The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Annals of internal medicine, 141(9), 662-673.
• Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., & Xing, X. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine. 382, 1199-207.
• McCutchan, F. E. (2006). Global epidemiology of HIV. Journal of medical virology, 78(S1), S7-S12.
• Narayanan, N., Lacy, C. R., Cruz, J. E., Nahass, M., Karp, J., Barone, J. A., & Hermes‐DeSantis, E. R. (2018). Disaster preparedness: biological threats and treatment options. Pharmacotherapy: The journal of human pharmacology and drug therapy, 38(2), 217-234.
• Olsen, S. J., Chang, H. L., Cheung, T. Y. Y., Tang, A. F. Y., Fisk, T. L., Ooi, S. P. L., & Hsu, K. H. (2003). Transmission of the severe acute respiratory syndrome on aircraft. New england journal of medicine, 349(25), 2416-2422.
• Pechous, R. D., Sivaraman, V., Stasulli, N. M., & Goldman, W. E. (2016). Pneumonic plague: the darker side of Yersinia pestis. Trends in microbiology, 24(3), 190-197.
• Petersen, L. R., Jamieson, D. J., Powers, A. M., & Honein, M. A. (2016). Zika virus. New england journal of medicine, 374(16), 1552-1563.
• Rega, P., Guinness, M., & McMahon, C. (2017). Tularemia–A Review with Concern for Bioterrorism. medical research archives, 5(8), 1-15.
• Roy, C., Reed, D., & Hutt, J. (2010). Aerobiology and inhalation exposure to biological select agents and toxins. Veterinary pathology, 47(5), 779-789.
• Spengler, J. R., Ervin, E. D., Towner, J. S., Rollin, P. E., & Nichol, S. T. (2016). Perspectives on West Africa Ebola virus disease outbreak, 2013–2016. Emerging infectious diseases, 22(6), 956-963.
• Sullivan, J., & Brannan, S. (2020). Hemorrhagic fevers. In J. Hidalgo & L. Woc-Colburn (Eds.), Highly Infectious Diseases in Critical Care (pp. 119-138): Springer.
• Taubenberger, J. K., & Morens, D. M. (2006). 1918 Influenza: the mother of all pandemics. Revista biomedica, 17(1), 69-79.
• World Health Organization (WHO) (2008). “Definitions: emergencies”. URL: https://www.who.int/hac/about/definitions/en/ (Erişim Tarihi: 17.04.2020)
• World Health Organization (WHO) (2018). Global health observatory data: URL: https://www.who.int/gho/hiv/en/ (Erişim Tarihi: 26.04.2020)
• World Health Organization (WHO). (2020). “Coronavirus disease (COVID-19) outbreak situation”. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Erişim Tarihi: 31.05.2020)
• Yaman, M., & Düger, Y. (2017). Afet yönetiminde kavramsal çerçeve ve Türkiye'de afet yönetiminin genel tarihsel gelişimi. In Ö. Önder & M. Yaman (Eds.), Afet Yönetimi (pp. 1-26). Bursa: Ekin Basım Yayın.
• Yu, I. T., Li, Y., Wong, T. W., Tam, W., Chan, A. T., Lee, J. H., & Ho, T. (2004). Evidence of airborne transmission of the severe acute respiratory syndrome virus. New england journal of medicine, 350(17), 1731-1739.
• Zhang, J.-C., Sun, L., & Nie, Q.-H. (2010). Botulism, where are we now? Clinical toxicology, 48(9), 867-879.
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Niu, P. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New england journal of medicine. 727-33.